article thumbnail

Amylyx to pull failed ALS drug Relyvrio from market, cut 70% of staffers

Fierce Pharma

Amylyx Pharmaceuticals is keeping a promise by pulling the amyotrophic lateral sclerosis (ALS) therapy Relyvrio off the market after the drug failed in a confirmatory trial. Amylyx is keeping a promise by pulling the amyotrophic lateral sclerosis (ALS) therapy Relyvrio off the market after the drug failed in a confirmatory trial.

Marketing 299
article thumbnail

Lilly CEO reaffirms commitment to Chinese market amid US threat against local biotechs

Fierce Pharma

and China, Eli Lilly’s CEO said the Indianapolis-based company remains committed to the Chinese market. At a time of heightened geopolitical tensions between the U.S. David Ricks’ visit to China comes as Lilly has several key drug applications under review at local regulators.

Marketing 249
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

After trial failure, will Amylyx pull ALS drug Relyvrio off the market?

Fierce Pharma

After reporting the failu | After reporting the failure of a confirmatory trial of its amyotrophic lateral sclerosis drug Relyvrio (AMX0035), Amylyx Pharmaceuticals is uncertain whether it will pull the treatment from the market in the U.S. and in Canada, where it is known as Albrioza.

Marketing 253
article thumbnail

Pharma marketing: Getting personalized with Fingerpaint Group

Fierce Pharma

Marketers operating in every sector are seeking ways to offer personalized, high-quality experiences to their target audiences. | How much influence will AI exert over pharma marketing? Is it a silver bullet solution to productivity and personalization challenges?

Marketing 233
article thumbnail

Marketing Ops: The New Revenue Hero

As data continues to play a starring role in today’s B2B organizations, both marketing and sales operations professionals are poised to solidify their place as critical revenue drivers.

article thumbnail

Why DTC isn’t, and is, marketing

World of DTC Marketing

CPG marketers are trying to maintain market share amid price increases and smaller product sizes, leading to a more significant jump in consumerism. But, in pharma marketing, the changes affect every product category. However, DTC marketing is different, much different. So what’s the opportunity for DTC marketers?

Marketing 252
article thumbnail

The 7 Ps of Marketing

Healthcare Success

As an engineering undergrad, I took a Marketing 101 class on a lark, seeking to better understand the psychology behind consumer behavior and developing products with a competitive edge. On the first day of class, we learned the fundamental concept of the 4 Ps of marketing. What Are the 7 Ps of Marketing? Positioning.

Marketing 112
article thumbnail

The Ultimate Marketing Efficiency Checklist

When times are tough and marketers are asked to do more with the same (or less), we have to make tough choices. Here are 7 creative ways marketers can work smarter (not harder) - with the resources you already have! However, you might be able to squeeze more value from the tools and processes you’re already using.

article thumbnail

Best Practices for Marketing Database Cleanse

Finding a vendor to cleanse and optimize your marketing database can be difficult if you don’t know what to look for. ZoomInfo has produced this eBook to help marketing leaders understand best practices around cost and value when it comes to choosing a B2B contact data provider. This buyer’s guide will cover: Buying Considerations.

article thumbnail

ABCs of Data Normalization for B2B Marketers

It’s not a far stretch to suggest that the topic isn’t exactly what gets marketers excited in their day-to-day workflow. However, if lead generation, reporting, and measuring ROI is important to your marketing team, then data normalization matters - a lot. Well, marketers rely on this grouping to reach their goals.

article thumbnail

How Intent Data Helps Marketers Convert A-List Accounts

One of the biggest challenges for any B2B marketer is understanding your prospects’ next move — who is most likely to buy and when. Without these insights, marketing campaigns can feel more like guesswork, with high investment and little return. We’re here to tell you there’s a better way.

article thumbnail

Marketing-Led Post-COVID-19 Growth Strategies

Any return to normalcy may seem far-off, but sales and marketing are on the front lines of restarting the economy. However, there’s no team better suited to lead that charge than the marketing department. Strategically aligning your systems and teams. Getting consensus on how to define “qualified leads”.

article thumbnail

Your Guide to Using Conversational Marketing to Drive Demand Generation

Enter conversational marketing — the new paradigm to tackling your business deals and converting prospects in minutes. Studies show the return on investment (ROI) of conversational marketing helps your marketing team drive revenue.

article thumbnail

Marketing-Led COVID-19 Growth Strategies: 2022 and Beyond

Businesses are tasked with beating pre-pandemic numbers, making marketing more essential than ever before. In this eBook, you’ll discover what it takes to develop and drive a successful marketing-led growth strategy. In this eBook, you’ll discover what it takes to develop and drive a successful marketing-led growth strategy.

article thumbnail

The Forrester Wave™: B2B Marketing Data Providers, Q2 2021

In our 24-criterion evaluation of B2B marketing data providers, we identified the 11 most significant vendors — Data Axle, Dun & Bradstreet, Enlyft, Global Database, InsideView, Leadspace, Oracle, SMARTe, Spiceworks Ziff Davis, TechTarget, and ZoomInfo Technologies — and researched, analyzed, and scored them.